IDARUBICIN IS ACTIVE ON MDR CELLS - EVALUATION OF DNA-SYNTHESIS INHIBITION ON P388 CELL-LINES

被引:13
|
作者
PETRINI, M
MATTII, L
VALENTINI, P
SABBATINI, ARM
GRASSI, B
GRANDI, M
机构
[1] UNIV PISA,DEPT HEMATOL,I-56100 PISA,ITALY
[2] FARMITALIA CARLO ERBA SPA,RES INST,DEPT EXPTL ONCOL,I-20014 NERVIANO,ITALY
关键词
IDARUBICIN; MULTIDRUG RESISTANCE; P-170; LEUKEMIA;
D O I
10.1007/BF01715052
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Multidrug resistance is frequently found in patients affected by hematological malignancies and has been related to a poor prognosis of acute leukemia. In the present paper we report results concerning the activity of idarubicin, an anthracycline derivative, on the leukemic P388 and P388 doxorubicin-resistant cell lines. The results clearly show that idarubicin inhibits DNA synthesis in the resistant cell line more actively than doxorubicin.
引用
收藏
页码:227 / 230
页数:4
相关论文
共 50 条